chevron_leftBack
T
As of 20 June 2026, Tripartite Therapeutics, Inc. has a market cap of $256.4M USD, ranking #19538 globally and #833 in Taiwan.
It ranks #1752 in the Healthcare sector, and #639 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$256.4MUSD
8.11B TWD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 11% | -7.8% | 78% | 78% | 78% | 78% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
7920
ISIN: TW0007920001
Shares Out.:
Shares Outstanding:
593.987M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.65 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.76B
3K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.83B
615%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$920.72M
259%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$805.08M
214%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$785.01M
206%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$581.1M
127%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
297K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
213K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
141K%
|
97.4
|
|
SIX: RO
|
$318.3B
124K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
111K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
107K%
|
15.1
|
chevron_leftBack